9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Long non-coding RNA-dependent mechanism to regulate heme biosynthesis and erythrocyte development

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In addition to serving as a prosthetic group for enzymes and a hemoglobin structural component, heme is a crucial homeostatic regulator of erythroid cell development and function. While lncRNAs modulate diverse physiological and pathological cellular processes, their involvement in heme-dependent mechanisms is largely unexplored. In this study, we elucidated a lncRNA (UCA1)-mediated mechanism that regulates heme metabolism in human erythroid cells. We discovered that UCA1 expression is dynamically regulated during human erythroid maturation, with a maximal expression in proerythroblasts. UCA1 depletion predominantly impairs heme biosynthesis and arrests erythroid differentiation at the proerythroblast stage. Mechanistic analysis revealed that UCA1 physically interacts with the RNA-binding protein PTBP1, and UCA1 functions as an RNA scaffold to recruit PTBP1 to ALAS2 mRNA, which stabilizes ALAS2 mRNA. These results define a lncRNA-mediated posttranscriptional mechanism that provides a new dimension into how the fundamental heme biosynthetic process is regulated as a determinant of erythrocyte development.

          Abstract

          LncRNAs modulate diverse physiological cellular processes, however, their involvement in heme-dependent processes are not yet clear. Here the authors reveal the role of lncRNA UCA1 in erythroid cell development.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: not found

          Braveheart, a long noncoding RNA required for cardiovascular lineage commitment.

          Long noncoding RNAs (lncRNAs) are often expressed in a development-specific manner, yet little is known about their roles in lineage commitment. Here, we identified Braveheart (Bvht), a heart-associated lncRNA in mouse. Using multiple embryonic stem cell (ESC) differentiation strategies, we show that Bvht is required for progression of nascent mesoderm toward a cardiac fate. We find that Bvht is necessary for activation of a core cardiovascular gene network and functions upstream of mesoderm posterior 1 (MesP1), a master regulator of a common multipotent cardiovascular progenitor. We also show that Bvht interacts with SUZ12, a component of polycomb-repressive complex 2 (PRC2), during cardiomyocyte differentiation, suggesting that Bvht mediates epigenetic regulation of cardiac commitment. Finally, we demonstrate a role for Bvht in maintaining cardiac fate in neonatal cardiomyocytes. Together, our work provides evidence for a long noncoding RNA with critical roles in the establishment of the cardiovascular lineage during mammalian development. Copyright © 2013 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            RIP-Chip: the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts.

            RNA targets of multitargeted RNA-binding proteins (RBPs) can be studied by various methods including mobility shift assays, iterative in vitro selection techniques and computational approaches. These techniques, however, cannot be used to identify the cellular context within which mRNAs associate, nor can they be used to elucidate the dynamic composition of RNAs in ribonucleoprotein (RNP) complexes in response to physiological stimuli. But by combining biochemical and genomics procedures to isolate and identify RNAs associated with RNA-binding proteins, information regarding RNA-protein and RNA-RNA interactions can be examined more directly within a cellular context. Several protocols--including the yeast three-hybrid system and immunoprecipitations that use physical or chemical cross-linking--have been developed to address this issue. Cross-linking procedures in general, however, are limited by inefficiency and sequence biases. The approach outlined here, termed RNP immunoprecipitation-microarray (RIP-Chip), allows the identification of discrete subsets of RNAs associated with multi-targeted RNA-binding proteins and provides information regarding changes in the intracellular composition of mRNPs in response to physical, chemical or developmental inducements of living systems. Thus, RIP-Chip can be used to identify subsets of RNAs that have related functions and are potentially co-regulated, as well as proteins that are associated with them in RNP complexes. Using RIP-Chip, the identification and/or quantification of RNAs in RNP complexes can be accomplished within a few hours or days depending on the RNA detection method used.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation.

              Abnormal mitochondrial fission participates in the pathogenesis of many diseases. Long non-coding RNAs (lncRNAs) are emerging as new players in gene regulation, but how lncRNAs operate in the regulation of mitochondrial network is unclear. Here we report that a lncRNA, named cardiac apoptosis-related lncRNA (CARL), can suppress mitochondrial fission and apoptosis by targeting miR-539 and PHB2. The results show that PHB2 is able to inhibit mitochondrial fission and apoptosis. miR-539 is responsible for the dysfunction of PHB2 and regulates mitochondrial fission and apoptosis by targeting PHB2. Further, we show that CARL can act as an endogenous miR-539 sponge that regulates PHB2 expression, mitochondrial fission and apoptosis. Our present study reveals a model of mitochondrial fission regulation that is composed of CARL, miR-539 and PHB2. Modulation of their levels may provide a new approach for tackling apoptosis and myocardial infarction.
                Bookmark

                Author and article information

                Contributors
                zhoujx@ihcams.ac.cn
                shilihongxys@ihcams.ac.cn
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                22 October 2018
                22 October 2018
                2018
                : 9
                : 4386
                Affiliations
                [1 ]GRID grid.461843.c, State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, ; Tianjin, 300020 China
                [2 ]ISNI 0000 0001 0662 3178, GRID grid.12527.33, Center for Stem Cell Medicine, Chinese Academy of Medical Sciences, ; Beijing, 100730 China
                [3 ]ISNI 0000 0000 9729 0286, GRID grid.464478.d, Tianjin Key Laboratory of Food and Biotechnology, School of Biotechnology and Food Science, , Tianjin University of Commerce, ; Tianjin, 300134 China
                [4 ]ISNI 0000 0004 1762 2623, GRID grid.410775.0, Japanese Red Cross Society, Department of Research and Development, Central Blood Institute, ; Tokyo, 105-8521 Japan
                [5 ]RIKEN BioResource Research Center, Cell Engineering Division, Ibaraki, 305-0074 Japan
                [6 ]ISNI 0000 0001 2248 6943, GRID grid.69566.3a, Department of Integrative Genomics Tohoku Medical Megabank, , Tohoku University, ; Sedai, 980-8573 Japan
                [7 ]ISNI 0000000086837370, GRID grid.214458.e, Department of Cell and Developmental Biology, , University of Michigan Medical School, ; Ann Arbor, MI 48109 USA
                [8 ]ISNI 0000 0001 2167 3675, GRID grid.14003.36, Wisconsin Institutes for Medical Research, Paul Carbone Cancer Center, Department of Cell and Regenerative Biology, , University of Wisconsin School of Medicine and Public Health, ; Madison, WI 53562 USA
                Article
                6883
                10.1038/s41467-018-06883-x
                6197277
                30349036
                e85c8d49-f952-4e5d-b844-dc5b67f76469
                © The Author(s) 2018

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 17 November 2017
                : 2 October 2018
                Funding
                Funded by: CAMS Initiative for Innovative Medicine (2016-I2M-1-018 to J.L)
                Funded by: CAMS Initiative for Innovative Medicine (2017-I2M-1-015 to J.G.)
                Funded by: FundRef https://doi.org/10.13039/100000009, Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.);
                Award ID: DK50107
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100006606, Natural Science Foundation of Tianjin City (Natural Science Foundation of Tianjin);
                Award ID: 15JCYBJC54500
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100001809, National Natural Science Foundation of China (National Science Foundation of China);
                Award ID: 31471291
                Award ID: 81870089
                Award Recipient :
                Funded by: National Key Research and Development Program of China Stem Cell and Translational Research (2016YFA0102300 and 2017YFA0103102 to L.S.) CAMS Initiative for Innovative Medicine (2016-I2M-3-002 to L.S) CAMS Medical Epigenetics Research Center (2017PT31035)
                Categories
                Article
                Custom metadata
                © The Author(s) 2018

                Uncategorized
                Uncategorized

                Comments

                Comment on this article